186 related articles for article (PubMed ID: 10767798)
41. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
42. Interferon gamma protects against hepatic tumor growth in rats by increasing Kupffer cell tumoricidal activity.
Karpoff HM; Tung C; Ng B; Fong Y
Hepatology; 1996 Aug; 24(2):374-9. PubMed ID: 8690407
[TBL] [Abstract][Full Text] [Related]
43. High-intensity focused ultrasound combined with herpes simplex virus thymidine kinase gene-loaded ultrasound-targeted microbubbles improved the survival of rabbits with VX₂ liver tumor.
Zhou SJ; Li SW; Wang JJ; Liu ZJ; Yin GB; Gong JP; Liu CA
J Gene Med; 2012; 14(9-10):570-9. PubMed ID: 22941868
[TBL] [Abstract][Full Text] [Related]
44. HSV-1-based amplicon particles are able to transduce cells of feline origin with genes encoding biologically functional feline IL-10 or IL-6.
Vögtlin A; Fraefel C; Kocherhans R; Leutenegger CM; Frei K; Fontana A; Ackermann M
Vet Microbiol; 2002 Apr; 86(1-2):103-13. PubMed ID: 11888694
[TBL] [Abstract][Full Text] [Related]
45. The roles of macrophages and nitric oxide in interleukin-3-enhanced HSV-Sr39tk-mediated prodrug therapy.
Yu CF; Hong JH; Chiang CS
PLoS One; 2013; 8(2):e56508. PubMed ID: 23441198
[TBL] [Abstract][Full Text] [Related]
46. Targeted gene therapy and in vivo bioluminescent imaging for monitoring postsurgical recurrence and metastasis in mouse models of liver cancer.
He Q; Yao CL; Li L; Xin Z; Jing ZK; Li LX
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525931
[TBL] [Abstract][Full Text] [Related]
47. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
[TBL] [Abstract][Full Text] [Related]
48. Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception.
Oguchi T; Funahashi Y; Yokoyama H; Nishizawa O; Goins WF; Goss JR; Glorioso JC; Yoshimura N
Gene Ther; 2013 Feb; 20(2):194-200. PubMed ID: 22402319
[TBL] [Abstract][Full Text] [Related]
49. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
[TBL] [Abstract][Full Text] [Related]
50. Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.
Markert JM; Cody JJ; Parker JN; Coleman JM; Price KH; Kern ER; Quenelle DC; Lakeman AD; Schoeb TR; Palmer CA; Cartner SC; Gillespie GY; Whitley RJ
J Virol; 2012 May; 86(9):5304-13. PubMed ID: 22379082
[TBL] [Abstract][Full Text] [Related]
51. Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.
Toda M; Martuza RL; Rabkin SD
Gene Ther; 2001 Feb; 8(4):332-9. PubMed ID: 11313808
[TBL] [Abstract][Full Text] [Related]
52. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma.
Qian C; Idoate M; Bilbao R; Sangro B; Bruña O; Vázquez J; Prieto J
Hum Gene Ther; 1997 Feb; 8(3):349-58. PubMed ID: 9048202
[TBL] [Abstract][Full Text] [Related]
53. Helium pneumoperitoneum reduces tumor recurrence after curative laparoscopic liver resection in rats in a tumor-bearing small animal model.
Schmeding M; Schwalbach P; Reinshagen S; Autschbach F; Benner A; Kuntz C
Surg Endosc; 2003 Jun; 17(6):951-9. PubMed ID: 12632132
[TBL] [Abstract][Full Text] [Related]
54. Interleukin 10 mediated by herpes simplex virus vectors suppresses neuropathic pain induced by human immunodeficiency virus gp120 in rats.
Zheng W; Huang W; Liu S; Levitt RC; Candiotti KA; Lubarsky DA; Hao S
Anesth Analg; 2014 Sep; 119(3):693-701. PubMed ID: 25137003
[TBL] [Abstract][Full Text] [Related]
55. Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.
Kuriyama S; Kikukawa M; Masui K; Okuda H; Nakatani T; Akahane T; Mitoro A; Tominaga K; Tsujinoue H; Yoshiji H; Okamoto S; Fukui H; Ikenaka K
Int J Cancer; 1999 Oct; 83(3):374-80. PubMed ID: 10495430
[TBL] [Abstract][Full Text] [Related]
56. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy.
Sasaki K; Chancellor MB; Goins WF; Phelan MW; Glorioso JC; de Groat WC; Yoshimura N
Diabetes; 2004 Oct; 53(10):2723-30. PubMed ID: 15448108
[TBL] [Abstract][Full Text] [Related]
57. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
[TBL] [Abstract][Full Text] [Related]
58. Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.
Satoh Y; Esche C; Gambotto A; Shurin GV; Yurkovetsky ZR; Robbins PD; Watkins SC; Todo S; Herberman RB; Lotze MT; Shurin MR
J Exp Ther Oncol; 2002; 2(6):337-49. PubMed ID: 12440225
[TBL] [Abstract][Full Text] [Related]
59. Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer.
Bennett JJ; Malhotra S; Wong RJ; Delman K; Zager J; St-Louis M; Johnson P; Fong Y
Ann Surg; 2001 Jun; 233(6):819-26. PubMed ID: 11371740
[TBL] [Abstract][Full Text] [Related]
60. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.
Barajas M; Mazzolini G; Genové G; Bilbao R; Narvaiza I; Schmitz V; Sangro B; Melero I; Qian C; Prieto J
Hepatology; 2001 Jan; 33(1):52-61. PubMed ID: 11124820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
